STACKLOC

What this means for you

Not registered yet, but its 12 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98899757

Mark type

Stylized text

Filed

12 Dec 2024

Published for opposition

01 Apr 2025

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.

Owner

• Tesseract Medical Research, LLC, Laguna Hills, CA, US
• Tesseract Medical Research, LLC, Laguna Hills, CA, US

Prosecution history

• 23 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 23 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 26 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
• 20 Aug 2025 — USE AMENDMENT FILED
• 25 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 20 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
• 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 01 Apr 2025 — PUBLISHED FOR OPPOSITION
• 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 10 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 06 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 06 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 25 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED